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Background: Pain and anxiety occurring from cardiovascular disease are associated with long-term health risks.
Integrative medicine (IM) therapies reduce pain and anxiety in small samples of hospitalized cardiovascular patients
within randomized controlled trials; however, practice-based effectiveness research has been limited. The goal
of the study is to evaluate the effectiveness of IM interventions (i.e., bodywork, mind-body and energy therapies,
and traditional Chinese medicine) on pain and anxiety measures across a cardiovascular population.
Methods: Retrospective data obtained from medical records identified patients with a cardiovascular ICD-9 code
admitted to a large Midwestern hospital between 7/1/2009 and 12/31/2012. Outcomes were changes in
patient-reported pain and anxiety, rated before and after IM treatments based on a numeric scale (0-10).
Results: Of 57,295 hospital cardiovascular admissions, 6,589 (11.5%) included IM. After receiving IM therapy,
patients averaged a 46.5% (p-value < 0.001) decrease in pain and a 54.8% (p-value < 0.001) decrease in anxiety.
There was no difference between treatment modalities on pain reduction; however, mind-body and energy
therapies (p-value < 0.01), traditional Chinese medicine (p-value < 0.05), and combination therapies (p-value < 0.01)
were more effective at reducing anxiety than bodywork therapies. Each additional year of age reduced the odds
of receiving any IM therapy by two percent (OR: 0.98, p-value < 0.01) and females had 96% (OR: 1.96, p-value < 0.01)
higher odds of receiving any IM therapy compared to males.
Conclusions: Cardiovascular inpatients reported statistically significant decreases in pain and anxiety following care
with adjunctive IM interventions. This study underscores the potential for future practice-based research to investigate
the best approach for incorporating these therapies into an acute care setting such that IM therapies are most
appropriately provided to patient populations.
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Pain and anxiety occurring from acute care for cardio-
vascular disease (CVD) are associated with long-term
health risks. Specifically, preoperative anxiety and acute
postoperative non-anginal pain in cardiac patients have
been found to predict persistent postoperative pain up to
24 months after surgery [1]. Furthermore, anxiety shortly
after hospitalization for myocardial infarction has been re-
ported as a strong predictor of recurrent myocardial in-
farction [2]. Given that pain and anxiety symptoms add to
the physical and psychosocial burden of post-operative
CVD patients, it is important to find effective approaches
to ameliorate these symptoms.
Pharmacological symptom management among cardio-
vascular patients, while often appropriate and necessary,
presents challenges such as side effects, limited effective-
ness, and risk of adverse events [3]. In 2005, the American
College of Cardiology Foundation Task Force recommended
consideration of non-pharmacological options for cardio-
vascular patients, including the use of complementary and
alternative medicine (CAM) therapies [4]. A 2012 system-
atic review of hospitals and outpatient clinics reported
that between four and sixty-one percent of cardiovascular
patients use CAM for managing cardiovascular conditions
and maintaining general health [5]. Integrative medicine
(IM) includes the use of CAM therapies, such as massage,
acupuncture, and mind-body therapies, in conjunction
with conventional medicine.
Several systematic reviews report on efficacy of IM for
CVD-related outcomes and risk factors including blood
pressure [6-9], blood lipids and cholesterol [9], and psy-
chosocial outcomes [9] in outpatient settings. Although
there is some evidence for efficacy, conclusions are lim-
ited by methodological challenges [4,6-9].
For inpatients with cardiovascular diagnoses, random-
ized controlled trials specifically focused on the use of IM
therapies for symptom management have reported im-
provements in pain and anxiety, among other outcomes
[10-17]. Trials are important for testing the efficacy of
these therapies; however, it has been suggested that the evi-
dence hierarchy that prioritizes RCTs over other methods
may warrant revising for the examination of certain inter-
ventions [18]. Real-world observational data is critical for
better understanding the effectiveness of integrative ther-
apies for cardiovascular inpatients [19], and observational
methods may be particularly appropriate for studying
IM, despite the inherent limitation of not being experi-
mental [20]. Practice-based research is also important for
improving clinical practice by delivering recommended
care in the most appropriate manner for specific popula-
tions [18,21].
In 2010, our research group reported a 55.8% average
reduction in pain with IM use across 1,837 inpatients
at Abbott Northwestern Hospital (ANW), based on aretrospective medical record review; however, results for
cardiovascular patients were not separately analyzed at
that time [22]. In the current study, we evaluate the effect-
iveness of IM therapy, as an adjunct to standard care, for
treating pain and anxiety, focusing on a large, inpatient
cardiovascular population at ANW. To our knowledge,
this is the first study in which multiple IM therapies are
studied using practice-based research methodology among
cardiovascular inpatients to treat pain and anxiety.
Methods
Study design and setting
This retrospective, practice-based research study of car-
diovascular inpatients was conducted at ANW, a 630-bed
teaching and specialty hospital in Minneapolis, MN. The
Penny George Institute for Health and Healing (PGIHH)
at ANW was founded in 2003 and offers hospitalized pa-
tients, through electronic physician and nurse referrals, a
wide-array of integrative health services at no charge to
patients [23]. All IM practitioners at PGIHH are formally
trained and have necessary licensure and/or certification
in their area of specialty (e.g., aromatherapy, acupuncture,
massage, music). Referral criteria include: (a) the patient is
able to participate in integrative health intervention, and
(b) patient concerns include pain, anxiety/stress, elimin-
ation problems, nausea/vomiting, insomnia, coping with
change in health/well-being, or maintaining/prolonging a
pregnancy.
Study population
All cardiovascular inpatients age 18 years or older at
ANW, who were admitted between July 1, 2009 and
December 31, 2012, were included in the study popula-
tion. Patients seen as outpatients, in the emergency room,
and who were in the hospital solely for observation were
excluded. Medical record data were obtained on all eligible
inpatients and cardiovascular patients were retrospectively
identified. All patients whose medical record data were ob-
tained gave written permission upon hospital admission to
use their records for research purposes.
The study population included those with diseases of
the circulatory system, identified using the International
Classification of Diseases (ICD), 9th Revision, Clinical
Modification diagnosis codes (390-459). Any admission
that had at least one of these ICD-9 codes as the admis-
sion’s primary or secondary diagnosis or any hospital
encounter-level diagnosis was eligible for the study.
We created non-mutually exclusive indicators pertain-
ing to five circulatory system diseases: diseases of arteries,
arterioles and capillaries (440-448); cerebrovascular dis-
ease (430-438); hypertensive disease (401-405); ischemic
heart disease (410-414); and diseases of pulmonary circu-
lation (415-417). Patients of all other circulatory system
diseases were grouped into an ‘other’ category.
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Board of Allina Health with a waiver of informed consent.Measurements
Demographic and admission characteristics
Data extracted from medical records included patient
age at time of admission, sex, race, marital status, and
health insurance status. The data included the All Patient
Refined Diagnostic Related Groups (APR-DRG) [24]
severity of illness measures calculated from patients’
diagnoses codes. The measure includes four categories
of severity: 1) minor, 2) moderate, 3) major, and 4) ex-
treme. Data pertaining to each IM session were routinely
documented in a customized documentation flowsheet
within the medical records.Integrative medicine therapies
IM practitioners used their clinical judgment to provide
therapies, within their scope of practice, they deemed
necessary and therapeutic for each patient, after consult-
ing with the patient. Many patients received IM therapy
numerous times throughout their hospital admission.
The term ‘session’ is used to define each unique adminis-
tration of IM therapy, distinguished by time of procedure,
within a hospital admission. For the present analyses, IM
therapies were placed into one of three broad categories:
bodywork (BW), which included craniosacral therapy,
medical massage, and reflexology; mind-body and energy
therapies (MBE), which was divided into separate mind-
body and energy subcategories; and traditional Chinese
medicine (TCM), which included acupressure, acupunc-
ture, and Korean hand therapy. Importantly, patients could
receive therapy from more than one category during each
session, which has been defined as combination therapies.
The presence or absence of each of these IM therapies was
coded at each session such that BW, MBE, TCM, and any
combination of these therapies were mutually exclusive.Pain and anxiety scores
IM practitioners collected patients’ self-reported pain
and anxiety scores directly prior to and after each IM
session. Practitioners requested patients to provide a sin-
gle number to indicate the level of pain they were cur-
rently experiencing on an 11-point numeric rating scale
where 0 was defined as ‘no pain’ and 10 was defined as
‘worst pain imaginable’. Similarly, practitioners recorded
anxiety scores using the same methodology, where 0 was
‘no anxiety’ and 10 was ‘worst anxiety imaginable’. The pri-
mary endpoints were changes in pain and anxiety scores,
calculated by subtracting the pre-score from the post-
score. Zero to 10 numeric rating scales for pain have been
found valid and reliable [25,26].Analytic data set
A total of 57,444 cardiology-related hospital admissions
were identified from medical records. During data clean-
ing, 149 hospital admissions were removed due to missing
demographic data (51 admissions) or inability to deter-
mine severity of illness (98 admissions), resulting in
57,295 cardiology admissions from 37,259 unique patients.
Of the 57,295 admissions, 6,589 (11.5%) had 16,344 IM
therapy sessions (average of 2.48 per admission). In many
cases, practitioners were unable to collect pre- or post-
pain and anxiety scores or patients reported no pain or
anxiety. Only patients who reported pre- and post-pain
scores and/or pre- and post-anxiety scores, and pre-pain/
pre-anxiety scores greater than zero, were included in the
subsequent analyses examining changes in pain and anx-
iety after receiving IM therapy.
Because IM therapies were observed at the hospital ad-
mission level, but pain and anxiety scores were assessed at
the IM session level, one session was randomly selected
from each remaining hospital admission in order to keep
the level of analysis consistent between the selection and
score change equations (see below). Thus, we dropped all
hospital admissions with only missing scores or pre-pain
or -anxiety scores equal to zero. This method produced a
sample of 54,163 hospital admissions for the pain model,
of which 3,457 (6%) had IM therapy, and 52,572 admis-




Logistic regression was used to predict the probability of
receiving any IM therapy during a hospital admission as
a function of patient demographics, circulatory system
disease diagnosis, severity, and health insurance status, and
odds ratios for each covariate are presented. A p-value of
less than 0.05 was used to signify statistical significance.
We used a random sample of 25,000 observations to test
the goodness-of-fit for our model using the Hosmer-
Lemeshow test [27]. We did not use the full sample be-
cause the Hosmer-Lemeshow test has been shown to likely
reject the null hypothesis of a good fit even for models that
fit well when the sample size is greater than 25,000 due to
increased statistical power [28]. The percent of admissions
correctly classified by the model were also calculated.
Pain and anxiety
First, to determine if IM therapies were associated with
reductions in pain and anxiety, paired t-tests were con-
ducted using the null hypothesis that the pre- and post-
pain or anxiety scores were equal.
Next, multivariate regression was used to estimate re-
ductions in pain and anxiety during IM sessions. Because
patients receiving IM therapy may systematically differ
Table 1 Abbott Northwestern cardiovascular inpatient






(n = 50,706) (n = 6,589)
Age (years ± SD) 67.8 ± 15.4 63.5 ± 14.8 <0.001
Sex (%)
Female 23,649 (46.6) 4,076 (61.9) <0.001
Male 27,057 (53.4) 2,513 (38.1) <0.001
Race (%)
White 45,285 (89.3) 6,058 (91.9) <0.001
African American 3,550 (7.0) 327 (5.0) <0.001
Asian 945 (1.9) 106 (1.6) 0.147
Other 926 (1.8) 98 (1.5) 0.051
Marital Status (%)
Married 26,475 (52.2) 3,572 (54.2) 0.002
Widow 9,821 (19.4) 977 (14.8) <0.001
Divorced 4,865 (9.6) 723 (11.0) <0.001
Single 9,545 (18.8) 1,317 (20.0) 0.023
Circulatory System Disease (%)
Arteries, Arterioles & Capillaries 4,379 (8.6) 427 (6.5) <0.001
Cerebrovascular 5,994 (11.8) 863 (13.1) 0.003
Hypertension 28,556 (56.3) 4,207 (63.8) <0.001
Ischemic Heart Disease 15,016 (29.6) 1,278 (19.4) <0.001
Pulmonary Circulation 2,408 (4.7) 481 (7.3) <0.001
Other 23,485 (46.3) 3,365 (51.1) <0.001
APR-DRG Severity (%)
Minor 7,926 (15.6) 497 (7.5) <0.001
Moderate 19,179 (37.8) 1,928 (29.3) <0.001
Major 18,049 (35.6) 2,745 (41.7) <0.001
Extreme 5,552 (10.9) 1,419 (21.5) <0.001
Health Insurance (%)
Commercial 15,084 (29.7) 2,368 (35.9) <0.001
Medicare 26,492 (52.2) 3,045 (46.2) <0.001
Medicaid 7,951 (15.7) 1,009 (15.3) 0.440
Other 1,179 (2.3) 167 (2.5) 0.291
aTotal n refers to number of hospital admissions and not individual patients.
bP-value calculated from two-tailed t-test comparing no IM therapy and IM
therapy, adjusted for equal or unequal variances as appropriate.
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ordinary least squares model could produce bias pa-
rameters when generalizing results. To address this bias, a
Heckman selection model [29] was used to account for se-
lection into the sample of IM therapy recipients.
To correctly identify the parameters that affect pain and
anxiety, at least one variable in the selection-equation
(i.e. utilization of IM therapy) should be specified which
predicts IM therapy use, but does not affect changes in
pain or anxiety. Since marital status and health insurance
status were expected to fit this criterion, our model
predicted selection into the sample of IM sessions
using all patient demographic, circulatory system dis-
ease diagnosis, severity, and health insurance variables
(the same set of covariates as our logistic regression
predicting IM therapy use). Changes in pain and anx-
iety scores were estimated using diagnosis, age, sex, race,
severity, and the inverse Mills ratio calculated from the
selection-equation to control for selection. Additionally,
we estimated a second model, which included IM therapy
categories, to determine if differential effects between the
categories existed.
All analyses were conducted in StataVersion 13 (StataCorp
LP; College Station, TX).
Results
Descriptive statistics
Of the 57,295 hospital admissions over the study period,
6,589 (11.5%) included IM therapy (Table 1). The mean
age of inpatients utilizing IM therapies (63.5 years) was
approximately four years younger than inpatients not re-
ceiving IM therapies (67.8 years). Fifteen percent of women
received IM therapy compared to only 9% of men. IM hos-
pital admissions were comprised of patients with signifi-
cantly higher illness severity. A total of 16,344 IM therapy
sessions were administered for an average of 2.48 sessions
per hospital admission (Table 2). BW comprised 45.7% of
IM sessions compared to 12.6% for MBE, 18.7% for TCM,
and 23.0% for combination therapies.
IM therapy utilization analysis
Similar to our descriptive statistics, older patients had
reduced odds of receiving any IM therapy in our logistic
regression model (Table 3), as each additional year of age
decreased the odds of any IM therapy use by 2% (odds
ratio (OR): 0.98, p-value < 0.01). Females had 96% (OR:
1.96, p-value < 0.01) higher odds of receiving any IM therapy
during a hospital admission compared to males. Compared
to other diseases of the circulatory system, admissions
from hypertensive disease (OR: 1.48, p-value < 0.01), and
diseases of pulmonary circulation (OR: 1.23, p-value <
0.01) were associated with increased odds of receiving IM
therapy, while ischemic heart disease (OR: 0.73, p-value <
0.01) and diseases of arteries, arterioles, and capillaries(OR: 0.75, p-value < 0.01) had reduced odds of receiving
IM therapy.
The p-value from a Hosmer-Lemeshow test was 0.58, in-
dicating a good fit. The model correctly classified 88% of
hospital admissions as receiving IM or not receiving IM.
Although this result was driven by the model’s under-
prediction of IM hospital admissions and the large propor-
tion of non-IM hospital admissions, there was a significant
difference (p-value < 0.001) in the predicted probability of
Table 2 Distribution of IM sessions by treatment type and circulatory system disease
Diseases of the circulatory system
Anya Arteries, Arterioles
& Capillaries





No. of Cardiovascular Admissions
with IM Therapy
6,589 427 863 4,207 1,278 481 3,365
No. of Total IM Sessions (%) 16,344 (100.0) 1,304 (100.0) 2,798 (100.0) 9,868 (100.0) 2,862 (100.0) 1,776 (100.0) 9,216 (100.0)
Bodywork (BW) (%) 7,477 (45.7) 638 (48.9) 1,479 (52.9) 4,455 (45.1) 1,359 (47.5) 947 (53.3) 4,554 (49.4)
Mind-Body and Energy
Therapies (MBE) (%)
2,059 (12.6) 168 (12.9) 311 (11.1) 1,108 (11.2) 371 (13.0) 238 (13.4) 1,197 (13.0)
Traditional Chinese
Medicine (TCM) (%)
3,051 (18.7) 176 (13.5) 482 (17.2) 2,108 (21.4) 398 (13.9) 186 (10.5) 1,367 (14.8)
Combination Therapy (%) 3,757 (23.0) 322 (24.7) 526 (18.8) 2,197 (22.3) 734 (25.6) 405 (22.8) 2,098 (22.8)
aIM sessions for patients with more than one circulatory system disease during an admission count under the ‘Any’ column as well as under the appropriate disease
columns. As such, the sum of individual disease columns does not equal the sum of the ‘Any’ column.
Table 3 Odds ratio for IM use among cardiovascular
inpatientsa
OR SE
Age (years) 0.98b 0.00
Sex (Reference = Male)
Female 1.96b 0.06
Race (Reference =White)
African American 0.47b 0.03
Asian 0.57b 0.08
Other/Unknown 0.63b 0.07




Circulatory System Disease (Reference = Other)
Arteries, Arterioles & Capillaries 0.75b 0.04
Cerebrovascular 1.08 0.05
Hypertension 1.48b 0.04
Ischemic Heart Disease 0.73b 0.03
Pulmonary Circulation 1.23b 0.07








aOdds ratios from logistic regression of 6,589 cardiology admissions. The
dependent variable was administration of IM therapy during admission.
OR indicates odds ratio; SE, standard error.
bp < 0.01.
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group (predicted probability = 0.16) and the non-IM hos-
pital admissions group (predicted probability = 0.11).
Pain and anxiety analysis
Sessions with IM therapy resulted in, on average, a 46.5%
(p-value < 0.001) decrease in pain score (Table 4). Anxiety
scores decreased by an average of 54.8% (p-value < 0.001)
after the administration of IM therapies (Table 4).
A Heckman selection model was used to account for
selection into the sample of IM therapy recipients. Re-
sults from this model predict that for a male with mean
age (67.3), mean inverse Mills ratio (2.05), and the modal
value of all categorical variables (i.e. White, hypertension
diagnosis, and moderate severity), IM therapy was asso-
ciated with a 1.81 (p-value < 0.001) point reduction in
pain (calculated from coefficients shown in Base Model;
Table 5). This result represents a 36.2% (p-value < 0.001)
reduction in pain for a male with the mean pain pre-
score (5.00). For a female with the same admission attri-
butes, IM therapy was associated with a 40.6% (p-value <
0.001) reduction in pain. When IM therapy categories
were included in the regression analysis, we found no sig-
nificant difference by IM therapy type. The inverse Mills
ratio had an insignificant effect on pain, suggesting that
selection bias was not present.
The Heckman selection model predicted a 2.28 (p-value <
0.001) point decrease (Table 5) or a 41.6% (p-value <
0.001) reduction in anxiety score for a male with mean
age (67.3), mean inverse Mills ratio (2.36), and the modal
value of all categorical variables with the mean anxiety
pre-score (5.48). For females, IM therapy was associated
with a 51.6% (p-value < 0.001) reduction in anxiety. At the
mean pre-anxiety score, MBE (12.2 percentage points),
TCM (7.7 percentage points), and combination (6.2 per-
centage points) therapies were all more effective than
BW therapies. Additionally, MBE therapy was 6.0 per-
centage points more effective than combination therapy.










Any treatment No. Pain Obs 5,981 454 713 3,702 1,122 574 3,180
% Decrease in Pain 46.5 46.8 49.5 45.2 47.6 49.2 48.2
SE 0.5 1.7 1.4 0.6 1.1 1.5 0.6
No. Anxiety Obs 3,109 227 293 1,663 696 370 1,871
% Decrease in Anxiety 54.8 53.1 55.0 53.2 53.0 52.9 55.2
SE 0.6 2.2 1.8 0.8 1.2 1.6 0.7
BW No. Pain Obs 2,761 212 395 1,644 532 303 1,580
% Decrease in Pain 46.6 45.4 50.7 44.9 48.1 49.6 48.6
SE 0.6 2.4 1.7 0.8 1.5 2.0 0.8
No. Anxiety Obs 1,454 103 155 779 305 195 900
% Decrease in Anxiety 51.7 48.1 51.5 50.0 49.0 52.0 53.1
SE 0.8 3.2 2.4 1.1 1.8 2.1 1.0
MBE No. Pain Obs 318 26 25 173 49 32 173
% Decrease in Pain 41.8 54.6 44.0 41.2 41.3 43.9 42.3
SE 2.3 8.2 7.8 2.9 8.8 6.6 2.5
No. Anxiety Obs 290 16 28 141 57 25 167
% Decrease in Anxiety 57.0 67.3 62.7 55.3 59.8 55.7 56.0
SE 1.8 7.0 4.2 2.6 4.5 6.1 2.3
TCM No. Pain Obs 1,248 63 122 932 154 64 490
% Decrease in Pain 48.4 46.3 53.0 47.1 44.6 59.7 51.9
SE 1.3 4.9 3.6 1.5 3.6 4.9 1.8
No. Anxiety Obs 200 8 15 120 22 15 105
% Decrease in Anxiety 71.5 72.9 88.7 68.5 72.5 69.2 67.3
SE 2.6 10.5 5.2 3.8 6.7 8.4 4.0
Combination No. Pain Obs 1,654 153 171 953 387 175 937
% Decrease in Pain 45.7 47.6 45.0 44.4 48.8 45.5 46.8
SE 0.9 2.8 3.1 1.1 1.9 2.6 1.2
No. Anxiety Obs 1,165 100 95 623 312 135 699
% Decrease in Anxiety 55.3 54.3 53.2 53.8 54.2 51.8 55.9
SE 0.9 3.3 3.3 1.3 1.8 2.7 1.2
aBW indicates bodywork; MBE, mind-body and energy therapies; TCM, traditional Chinese medicine; SE, standard error. All results statistically significant (p < 0.001).
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iety, suggesting that selection bias was not present.
Discussion
This practice-based research study, using routinely-collected
electronic medical record data, assessed the effectiveness
of adjunctive IM therapy on pain and anxiety among car-
diovascular inpatients. Of 57,295 hospital admissions over
the study period, 6,589 (11.5%) included IM therapy.
Older patients had reduced odds of receiving any IM ther-
apy and females had 96% higher odds of receiving any IM
therapy compared to males. After receiving IM therapy,
patients averaged a 46.5% reduction in pain and a 54.8%
reduction in anxiety. For acute pain measured by a 0-10numeric rating scale, a clinically significant reduction in
pain is 20% for minimal noticeable improvement by pa-
tients, and between 35% and 44% reduction for a more
substantial improvement (for patients with moderate or
severe baseline pain, respectively) [30]; therefore, our
results may be interpreted as clinically significant as
well as statistically significant. The changes in pain
and anxiety we observed may be in addition to or con-
current with changes from analgesics and psychoactive
medications or other medical therapies. This study found
no difference between treatment modalities on pain
reduction; however, MBE, TCM, and combination ther-
apies were all more effective at reducing anxiety than
BW therapies.
Table 5 Predicted change in pain and anxiety scoresa
Base model Model including treatment types
Outcome Marginal effect SE Marginal effect SE
Pain
Age 0.00 0.01 0.00 0.01
Female -0.23 0.13 -0.23 0.13
Race (Reference =White)
African American -0.35 0.21 -0.35 0.21
Asian -0.35 0.25 -0.34 0.25
Other 0.25 0.29 0.24 0.29
Circulatory System Disease (Reference = Other)
Arteries, Arterioles & Capillaries -0.10 0.12 -0.11 0.12
Cerebrovascular 0.07 0.11 0.07 0.11
Hypertension 0.06 0.10 0.06 0.10
Ischemic Heart Disease -0.05 0.10 -0.05 0.10
Pulmonary Circulation 0.17 0.13 0.17 0.13
Severity (Reference = Minor)
Moderate -0.24 0.14 -0.24 0.14
Major -0.42b 0.19 -0.43b 0.19
Extreme -0.45 0.27 -0.46 0.28
Treatment Type (Reference = BW)
MBE . . 0.22 0.13
TCM . . -0.02 0.08
Combination . . -0.03 0.07
Inverse Mills Ratio -0.21 0.43 -0.22 0.43
Constant -1.22 0.72 -1.23 0.72
Anxiety
Age 0.03b 0.01 0.03b 0.01
Female -0.56b 0.28 -0.62b 0.28
Race(Reference =White)
African American -0.06 0.36 -0.02 0.36
Asian -0.12 0.37 -0.10 0.38
Other 0.86 0.52 0.95 0.53
Circulatory System Disease (Reference = Other)
Arteries, Arterioles & Capillaries -0.08 0.18 -0.05 0.18
Cerebrovascular 0.27 0.19 0.27 0.19
Hypertension 0.02 0.11 0.01 0.11
Ischemic Heart Disease -0.04 0.11 0.00 0.12
Pulmonary Circulation -0.05 0.20 -0.08 0.20
Severity (Reference = Minor)
Moderate -0.43 0.27 -0.50 0.27
Major -0.89b 0.44 -1.08b 0.45
Extreme -0.91 0.66 -1.19 0.66
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Table 5 Predicted change in pain and anxiety scoresa (Continued)
Treatment Type (Reference = BW)
MBE . . -0.67c 0.16
TCM . . -0.42b 0.20
Combination . . -0.34c 0.10
Inverse Mills Ratio -1.04 0.76 -1.26 0.77
Constant -1.12 1.41 -0.38 1.42
aMarginal effect of covariates on the change in pain and anxiety scores after administration of IM therapy from a Heckman selection model. Marital status and
health insurance were used as exclusion restrictions in the selection-equation. Hospital admissions for which all change in pain or anxiety score were missing were
excluded from this analysis. The pain sample consisted of 54,163 admissions, of whom 3,457 utilized IM therapies; the anxiety sample consisted of 52,572 admissions, of
whom 1,866 utilized IM therapies. BW indicates bodywork; MBE, mind-body and energy therapies; TCM, traditional Chinese medicine.
bp < 0.05.
cp < 0.01.
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wide range of practice models and arrays of services of-
fered, and both RCTs and observational studies comprise
a relatively small portion of the evidence base in the IM
field [31]. The present results are generally consistent with
previous reports of CAM for cardiovascular inpatients, al-
though research to date among cardiovascular inpatient
populations focuses only on bodywork and mind-body
and energy therapies, not traditional Chinese medicine/
acupuncture modalities. Several randomized trials involv-
ing preoperative [10] and postoperative [13-15] cardiovas-
cular inpatients compared massage therapy to standard
care with relaxation or rest and reported significant reduc-
tions in pain and anxiety scores on a 0-10 scale. A 2006
report of a randomized trial of open heart surgery patients
described an unquantified reduction in pre- and postoper-
ative pain in the intervention arm (a package of CAM
therapies including guided imagery and light massage)
compared with the standard care control [16]. A random-
ized trial among cardiac inpatients treated with healing
touch found a statistically significant 6.3 point reduction in
anxiety as measured by the State Trait Anxiety Inventory
(STAI) [11]. One randomized trial reported statistically
non-significant changes in pain and anxiety among post-
surgical cardiac patients receiving foot massage and guided
relaxation compared to controls; however, although not
significant, the authors reported a trend indicating the
interventions appeared to be effective [17]. Another ran-
domized trial of massage reported non-significant changes
in pain and anxiety in the intervention group [32], but as
noted by Braun and colleagues, the standard massage se-
quence used in that study may have limited the potential
efficacy [15].
The present study is unique for its practice-based
observational design and large sample of cardiovascu-
lar inpatients. Prior investigations have been random-
ized trials with smaller sample sizes and more limited
scope [10,11,13-17,32]. Observational data are import-
ant for understanding real-world clinical effectiveness
[19,21], and appropriately analyzed observational datahave been found to complement the results of random-
ized trials of cardiovascular outcomes [33]. Given the high
levels of CAM or IM usage by cardiovascular patients [5],
practice-based observational research on IM is important
for the evidence base on management of CVD symptoms
and recovery. An important strength of this study is our
use of a Heckman selection model to adjust for any non-
random selection of whether patients received IM therapy.
As a result of this adjustment, our results are generalizable
to cardiovascular patients at ANW. These results, how-
ever, may not generalize to other hospital settings.
This study is not without limitations. First, the present
results reflect only short-term changes in pain and anxiety.
Because clinical relevance may be limited with a focus on
short-term changes, further investigation into the long-
term effects of IM on pain and anxiety should be consid-
ered. Second, the IM practitioner who delivered the IM
therapy was also responsible for collection of the pre- and
post-IM therapy pain and anxiety scores. As a result, the
potential exists for social desirability or other response or
reporting bias. However, provider-collected scores are re-
flective of how pain and other symptoms are assessed in a
real-world acute care setting. Physicians, nurses, and other
care providers regularly ask patients to self-report their
rating of symptoms, and commonly used measures such
as the numeric rating scale have been reported on [25,26].
It has been recommended that clinical decisions be based
on information collected in this way [34]. Third, the ef-
fects of IM on pain scores are not separated from the pain
reduction impact of pain medications. Our findings only
reflect changes in pain and anxiety when IM therapies are
provided adjunctively to standard medical care, which
may include use of analgesics and psychoactive medica-
tions. However, because pain and anxiety are often only
partially resolved by medications [35-37], investigating the
use of IM therapies in conjunction with standard medical
care is an important next step in learning how to better
manage pain and anxiety in an acute care setting. Future
practice-based research should explore the interactive ef-
fects of IM therapy and pain medication by, for example,
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provision of the IM therapy. Finally, this study did not ex-
plore the potential biological mechanisms of IM under-
lying the observed pain and anxiety reduction; this area of
exploration is additionally warranted in future practice-
based research.
Conclusions
This study provided a unique opportunity to describe
and investigate the effectiveness of delivering IM therapy
to cardiovascular inpatients. Our results suggest that after
receiving adjunctive IM therapies, cardiovascular inpa-
tients reported statistically significant decreases in pain
and anxiety. This study lays preliminary groundwork for
future practice-based research to investigate the best ap-
proach for incorporating these therapies into an acute care
setting such that IM therapies are most appropriately pro-
vided to patient populations.
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